Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds | Patent Number 10857215

US 10857215 B2
Application Number14931329
Publication NumberUS 20160051645 A1
Pendency5 years, 1 month, 7 days
Filled DateNov 3, 2015
Priority DateApr 12, 2012
Publication DateFeb 25, 2016
Expiration DateApr 11, 2032
Inventor/ApplicantsGary E. Borodic
Martin A. Acquadro
Martin A Acquadro
ExaminesFOX, ALLISON M
Art Unit1633
Technology Center1600
Assignments
Athyrium Buffalo Lp
Current
Revance Therapeutics
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.